Announced
Financials
Tags
health care
Domestic
Private Equity
Single Bidder
Friendly
Acquisition
Majority
Pending
contract research organization
Private
United States
Biotechnology
Test Inspection and Certification (TIC)
Synopsis
ArchiMed-backed NAMSA, a medical device-focused contract research organization, agreed to acquire American Preclinical Services, a Minneapolis-based full service preclinical CRO. Financial terms were not disclosed. “With NAMSA’s trusted biocompatibility and biological safety solutions, coupled with both organization’s preclinical services, Sponsors now have a clear choice when partnering with the CRO industry’s foremost expert in medical device development and preclinical research,” Michael Conforti, APS President and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.